2-pivaloylbenzoic acid | 33148-54-8

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-pivaloylbenzoic acid
• 英文别名: 2-Pivaloylbenzoesaeure；2-(2,2-dimethylpropanoyl)benzoic acid
• CAS: 33148-54-8
• 化学式: C₁₂H₁₄O₃
• 分子量: 206.241
• InChiKey: MAUPYODWFFWAEZ-UHFFFAOYSA-N

物化性质

• 沸点：
  339.8±25.0 °C(Predicted)
• 密度：
  1.126±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  54.4
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2916399090

反应信息

• 作为反应物：
  描述：

  2-pivaloylbenzoic acid 在 sodium hydroxide 、 溴 作用下， 生成 1-(2-aminophenyl)-2,2-dimethylpropan-1-one
  参考文献：
  名称：

  Bettembourg,M.-C.; Brunesseaux,Y., Bulletin de la Societe Chimique de France, 1963, p. 2449 - 2451

  摘要：

  DOI：
• 作为产物：
  描述：

  3-tert-Butyl-3-hydroxy-1(3H)-benzofuranon 以 乙醇 为溶剂， 生成 2-pivaloylbenzoic acid
  参考文献：
  名称：

  Ring-Chain Tautomerism. Part 10. The Reaction of Oxocarboxylic Acids with Diazodiphenylmethane

  摘要：

  一系列羧酸酯化与二苯甲烷重氮化合物的速率系数已在30.0°C的乙醇或2-甲氧基乙醇中确定。这些速率以及与模型化合物的反应速率已用于估算羧酸酯的环-链互变异构的平衡常数。

  DOI：

  10.1135/cccc19991601

文献信息

• Trifluoroacetic acid catalyzed dibenzodiazocine synthesis: optimization and mechanism study
  作者：Na Zhao、Li Qiu、Xiao Wang、Jianzhong Li、Yi Jiang、Xiaobo Wan

  DOI：10.1016/j.tet.2012.09.050

  日期：2012.11

  electrochemical actuators, were synthesized via a novel, efficient acid-catalyzed reaction of 2-acylbenzoisocyanate at room temperature. Real-time NMR analysis and the captured intermediate showed the mechanism was an unprecedented cyclization of the isocyanate with the neighboring acyl group, followed by the dimerization.

  二苯并[ b，f ] [1,5]重氮电影，一类潜在的新型电化学致动器的组成部分，是通过在室温下进行新型的，有效的酸催化的2-酰基苯并异氰酸酯反应合成的。实时NMR分析和捕获的中间体表明，该机理是异氰酸酯与相邻酰基的空前环化，然后是二聚化。
• Modulators of TNF-alpha signaling
  申请人：Genzyme Corporation

  公开号：US20020119988A1

  公开（公告）日：2002-08-29

  The present invention provides compounds which are modulators of TNF-&agr; signaling and methods of use thereof for treating a patient having a TNF-&agr; mediated condition. The compounds can be represented by the following structural formulas: 1

  本发明提供了一种调节TNF-α信号的化合物，以及这些化合物的使用方法，用于治疗患有TNF-α介导疾病的患者。这些化合物可以用以下结构式表示：1
• SUBSTITUTE DIPHENYLAMINE COMPOUNDS USE THEREOF AS ANTITUMOR AGENTS
  申请人：SINOCHEM CORPORATION

  公开号：US20150011628A1

  公开（公告）日：2015-01-08

  The invention relates to substituted diphenylamine compounds using as antitumor agents. The structure of the compounds is represented as the general formula (I): The groups are as defined as specification. The compound represented by formula (I) showed potent antitumor activity, especially to cure or alleviate the cancer causing by cancer cells of human tissue or organ. The preferred cancers are: colon cancer, liver cancer, lymph cancer, lung cancer, esophageal cancer, breast cancer, central nervous system cancer, melanoma, ovarian cancer, cervical cancer, renal cancer, leukemia, prostatic cancer, pancreatic cancer, bladder cancer, rectal cancer, osteosarcoma, nasopharynx cancer or stomach cancer.

  该发明涉及以取代二苯胺化合物作为抗肿瘤药剂。化合物的结构表示为通式(I)：其中各个基团如规范所定义。由通式(I)表示的化合物显示出强效的抗肿瘤活性，特别是用于治疗或缓解由人体组织或器官的癌细胞引起的癌症。首选的癌症包括：结肠癌、肝癌、淋巴癌、肺癌、食管癌、乳腺癌、中枢神经系统癌、黑色素瘤、卵巢癌、宫颈癌、肾癌、白血病、前列腺癌、胰腺癌、膀胱癌、直肠癌、骨肉瘤、鼻咽癌或胃癌。
• Chemistry of neopentyl derivatives
  作者：A.J.M. Reuvers、H. van Bekkum、B.M. Wepster

  DOI：10.1016/s0040-4020(01)92843-1

  日期：1970.1

  The reaction of benzylmagnesium halides with t-butyl halides yields o- and p-t-butyltoluene in addition to neopentylbenzene. A study has been made of the influence of (i) the halide atoms present in both reactants, (ii) the purity of the magnesium used, (iii) the solvent in which the reaction is conducted, and (iv) the substituents in the aromatic ring of the benzyl Grignard reagent. The reaction of

  苄基卤化镁与叔丁基卤的反应除生成新戊基苯外，还生成邻位和对叔丁基甲苯。已经研究了（i）两种反应物中都存在的卤原子，（ii）所用镁的纯度，（iii）进行反应的溶剂和（iv）取代基中的取代基的影响。格氏试剂的芳环。还研究了叔丁基氯化镁与4-烷基苄基氯的反应。
• CONFORMATIONALLY RESTRICTED UREA INHIBITORS OF SOLUBLE EPOXIDE HYDROLASE
  申请人：Hammock D. Bruce

  公开号：US20070225283A1

  公开（公告）日：2007-09-27

  Inhibitors of the soluble epoxide hydrolase (sEH) are provided that incorporate multiple pharmacophores and are useful in the treatment of diseases.

  提供了可抑制可溶性环氧化物水解酶（sEH）的抑制剂，这些抑制剂结合了多种药效团，并且在治疗疾病方面具有用途。